Genomics for Health in Africa

Priority area: Public Health

The CoRE for Genomics for Health in Africa aims to leverage the potential of genomics to revolutionise healthcare in Africa. Genomics can provide a better understanding of rare diseases, cancers, and infections, which can lead to more effective treatments.

Combined with biochemical, biophysical, and structural analyses, genomics serves as a powerful tool for precision medicine and personalised treatment approaches. However, despite its enormous value, genomics is under-utilised in Africa due to insufficient infrastructure, resources, and scientific capacity.

This CoRE will build capacity for genomics-based diagnostics of rare diseases, cancers, and infections, coupled to investigating protein structure-function relationships and supporting optimal drug treatment and vaccine development. It will provide a unique and open platform to the African research community, to exploit the full potential of genomics coupled to protein structure function studies, as a fundamental tool to revolutionise public healthcare for both infectious and rare non-communicable diseases.

Co-Leads

Click the names of the Co-Leads to access their emails.

ARUA The Guild

Stellenbosch University, South Africa

University of Bern, Switzerland

University of Tübingen, Germany

Prof. Dr. Shahida Moosa - Head of Medical Genetics, Tygerberg Hospital

Prof. Dr. Tulio de Oliveira – Director, Centre for Epidemic Response and Innovation

Prof. Dr. Carmen Faso - Multidisciplinary Center for Infectious Diseases (MCID) Co-Chair and MCID Interfaculty Lecturer

Prof. Dr. Volker Thiel - MCID Co-Chair and Professor for Virology

Dr. Tobias Haack – Deputy-Director & Lead Physician, Institute of Medical Genetics and Applied Genomics; Center for Rare Diseases

Prof. Dr. Olaf Riess – Director of the Institute of Medical Genetics and Applied Genomics; Center for Rare Diseases; Center for Personalized Medicine